Free Trial

Sera Prognostics (SERA) Stock Price, News & Analysis

Sera Prognostics logo
$3.43 -0.25 (-6.79%)
Closing price 04:00 PM Eastern
Extended Trading
$3.42 -0.02 (-0.44%)
As of 04:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Sera Prognostics Stock (NASDAQ:SERA)

Key Stats

Today's Range
$3.39
$3.72
50-Day Range
$3.54
$6.65
52-Week Range
$3.25
$12.36
Volume
61,704 shs
Average Volume
135,323 shs
Market Capitalization
$129.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Remove Ads

Sera Prognostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

SERA MarketRank™: 

Sera Prognostics scored higher than 20% of companies evaluated by MarketBeat, and ranked 863rd out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Sera Prognostics are expected to decrease in the coming year, from ($0.96) to ($0.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sera Prognostics is -3.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sera Prognostics is -3.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Sera Prognostics has a P/B Ratio of 1.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Sera Prognostics' valuation and earnings.
  • Percentage of Shares Shorted

    3.51% of the float of Sera Prognostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Sera Prognostics has a short interest ratio ("days to cover") of 6.4.
  • Change versus previous month

    Short interest in Sera Prognostics has recently decreased by 4.31%, indicating that investor sentiment is improving.
  • Dividend Yield

    Sera Prognostics does not currently pay a dividend.

  • Dividend Growth

    Sera Prognostics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.51% of the float of Sera Prognostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Sera Prognostics has a short interest ratio ("days to cover") of 6.4.
  • Change versus previous month

    Short interest in Sera Prognostics has recently decreased by 4.31%, indicating that investor sentiment is improving.
  • News Sentiment

    Sera Prognostics has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.
  • MarketBeat Follows

    1 people have added Sera Prognostics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Sera Prognostics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $480,677.00 in company stock.

  • Percentage Held by Insiders

    15.80% of the stock of Sera Prognostics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    54.64% of the stock of Sera Prognostics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Sera Prognostics' insider trading history.
Receive SERA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sera Prognostics and its competitors with MarketBeat's FREE daily newsletter.

SERA Stock News Headlines

Elon Tax Shock?
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.
TD Cowen Sticks to Its Buy Rating for Sera Prognostics (SERA)
Sera Prognostics reports Q4 EPS (25c) vs. (25c) last year
See More Headlines

SERA Stock Analysis - Frequently Asked Questions

Sera Prognostics' stock was trading at $8.14 at the beginning of 2025. Since then, SERA shares have decreased by 57.9% and is now trading at $3.43.
View the best growth stocks for 2025 here
.

Sera Prognostics, Inc. (NASDAQ:SERA) issued its earnings results on Wednesday, March, 19th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by $0.02. The company had revenue of $0.02 million for the quarter, compared to analysts' expectations of $0.01 million.

Sera Prognostics (SERA) raised $75 million in an IPO on Thursday, July 15th 2021. The company issued 4,687,500 shares at a price of $15.00-$17.00 per share.

Shares of SERA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sera Prognostics investors own include Meta Platforms (META), JPMorgan Chase & Co. (JPM), Tesla (TSLA), NVIDIA (NVDA), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD).

Company Calendar

Last Earnings
3/19/2025
Today
4/01/2025
Next Earnings (Estimated)
5/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:SERA
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-36,240,000.00
Pretax Margin
-34,302.13%

Debt

Sales & Book Value

Annual Sales
$77,000.00
Price / Cash Flow
N/A
Book Value
$2.21 per share
Price / Book
1.55

Miscellaneous

Free Float
28,436,000
Market Cap
$129.19 million
Optionable
Optionable
Beta
0.89
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:SERA) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners